These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7534227)

  • 41. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
    Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2).
    Sugiura T; Berditchevski F
    J Cell Biol; 1999 Sep; 146(6):1375-89. PubMed ID: 10491398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
    Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
    Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
    Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
    J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
    Rankin CA; Suzuki K; Itoh Y; Ziemer DM; Grantham JJ; Calvet JP; Nagase H
    Kidney Int; 1996 Sep; 50(3):835-44. PubMed ID: 8872958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metalloproteinases regulate parietal endoderm differentiating and migrating in cultured mouse embryos.
    Behrendtsen O; Werb Z
    Dev Dyn; 1997 Feb; 208(2):255-65. PubMed ID: 9022062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
    Philip S; Bulbule A; Kundu GC
    J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
    Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.
    Esparza J; Vilardell C; Calvo J; Juan M; Vives J; Urbano-Márquez A; Yagüe J; Cid MC
    Blood; 1999 Oct; 94(8):2754-66. PubMed ID: 10515879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential.
    Capon F; Emonard H; Hornebeck W; Maquart FX; Bernard P
    Clin Exp Metastasis; 1999; 17(6):463-9. PubMed ID: 10763911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of gonadotrophin on cell and matrix retention and expression of metalloproteinases and their inhibitor in cultured human granulosa cells modelling corpus luteum function.
    Aston KE; Stamouli A; Thomas EJ; Vyas S; Iredale JP; Arthur MJ; Richardson MC
    Mol Hum Reprod; 1996 Jan; 2(1):26-30. PubMed ID: 9238653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions.
    Galis ZS; Muszynski M; Sukhova GK; Simon-Morrissey E; Libby P
    Ann N Y Acad Sci; 1995 Jan; 748():501-7. PubMed ID: 7695193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
    Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
    Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.
    Fabunmi RP; Baker AH; Murray EJ; Booth RF; Newby AC
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):335-42. PubMed ID: 8670128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel synthetic oleanane triterpenoid suppresses adhesion, migration, and invasion of highly metastatic melanoma cells by modulating gelatinase signaling axis.
    Sinha D; Dutta K; Ganguly KK; Biswas J; Bishayee A
    Mol Carcinog; 2015 Aug; 54(8):654-67. PubMed ID: 24510625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
    Galis ZS; Sukhova GK; Lark MW; Libby P
    J Clin Invest; 1994 Dec; 94(6):2493-503. PubMed ID: 7989608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Timp-1, -2 and -3 show coexpression with gelatinases A and B during mouse tooth morphogenesis.
    Sahlberg C; Reponen P; Tryggvason K; Thesleff I
    Eur J Oral Sci; 1999 Apr; 107(2):121-30. PubMed ID: 10232461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.